Studies have consistently evidenced the positive clinical, economic, and humanistic benefits
of pharmacist‐directed patient care in a variety of settings. Given the vast differences in …

Objectives: Patient care rounds are a key mechanism by which healthcare providers
communicate and make patient care decisions in the ICU but no synthesis of best practices …

Objectives: To provide a multiorganizational statement to update recommendations for
critical care pharmacy practice and make recommendations for future practice. A position …

Background Clinical and cost-effectiveness evidence are needed to justify the existence or
extension of routine clinical pharmacy services in hospital settings. Previous reviews have …

Neurocritical care is a distinct subspecialty focusing on the optimal management of acutely
ill patients with life-threatening neurologic and neurosurgical disease or with life-threatening …

Background: Many patients experience complications following critical illness; these are
now widely referred to as post–intensive care syndrome (PICS). An interprofessional …

Objectives: Surgical and medical ICU patients are at high risk of mortality and provide a
significant cost to the healthcare system. The aim of this study is to describe the effect of …

BACKGROUND: A clinical pharmacist is a key member of the antimicrobial multidisciplinary
team involved in patients' pharmacotherapy monitoring. The aim of this study was to …

OBJECTIVES: To describe the implementation of a TCC pharmacist into an established TCC
network, classify interventions performed, and quantify cost avoidance generated through …

This was an economic analysis of a 12-month, parallel arm, randomized controlled trial in
adult kidney recipients 6 to 36 months posttransplant (NCT03247322). All participants …